Hepatitis D Virus (HDV) Antigen
Phenobarbital, Confirmation, Urine
Culture, Eye (Routine)
Culture, Genital
Bacterial Culture, Upper Respiratory
E6 and E7 Gene Expression Detection Assay for Cervical Cancer (HPV OncoTect, QuantiVirus™)
Thyroiditis
Interferon-γ Receptor (IFNGR1) Deficiency
Beta-Hydroxybutyrate, Serum
Anthrax Antibody
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Clinical Utility
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now